Health Care :: NewYork-Presbyterian Ranks Number 1 in New York Magazine’s Best Hospitals Survey
NewYork-Presbyterian Hospital is ranked the overall #1 hospital in New York City, according to New York magazine’s 2006 “Best Hospitals” issue.
NewYork-Presbyterian Hospital is ranked the overall #1 hospital in New York City, according to New York magazine’s 2006 “Best Hospitals” issue.
By fine-tuning “fine-needle aspiration” biopsies with a super-fast genetic microarray technology, a team of surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City says they can greatly enhance the accuracy of these tests.
The American Medical Association?s (AMA) House of Delegates unanimously and enthusiastically passed a resolution introduced by The Endocrine Society and other concerned organizations urging the U.S. Food and Drug Administration (FDA) to increase its oversight and regulation of so-called bioidentical hormones.
Some ?chocoholics? who just couldn?t give up their favorite treat to comply with a study to test blood stickiness have inadvertently done their fellow chocolate lovers – and science – a big favor.
A visiting biologist at the University of California, San Diego and her colleagues in Africa and Britain have shown that there are close linkages between outbreaks of Ebola hemorrhagic fever in human and wildlife populations, and that climate may influence the spread of the disease.
Vaccinating mice with embryonic stem cells appears to have prevented lung cancer in the mice, a team of researchers say.
Newly presented data indicate that treatment with SYMBICORT? (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly greater improvements in lung function, and a lower risk of asthma worsening episodes, compared to budesonide and/or formoterol used alone. In addition, data also showed that SYMBICORT was generally well-tolerated, with an adverse event profile similar to that of its individual components. These study results, involving patients with mild to moderate persistent asthma, were presented today at the American College of Allergy, Asthma & Immunology’s (ACAAI) annual scientific sessions held in Philadelphia on November 9-15, 2006.
Children treated with PULMICORT RESPULES? (budesonide inhalation suspension) either once or twice daily experienced a significantly greater increase in the percentage of asthma-control days compared to those receiving placebo. These results are being presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia on November 9-15. Asthma-control days were defined as days when children were free of symptoms and did not use rescue medications during the day and night. Control of asthma symptoms during the day and night and reduction of the need for rescue medication is an important goal of asthma therapy in keeping with current National Asthma Education and Prevention Program (NAEPP) guidelines.
For the first time, researchers have successfully used a rabbit’s cells to grow heart-valve-shaped tissue inside the animal’s body, according to research reported at the American Heart Association’s Scientific Sessions 2006.
A program of time-specific ‘blister’ packaging, individualized patient education by a pharmacist and bimonthly pharmacist followup increases medication adherence from 61.2 percent to 96.9 percent in elderly patients at risk for heart disease.